CoChat

Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts

Open access
Dadu, Anant, Satone, Vipul, Kaur, Rachneet, Hashemi, Sayed Hadi, Leonard, Hampton, Iwaki, Hirotaka, Makarious, Mary B., Billingsley, Kimberley J., Bandres‐Ciga, Sara, Sargent, Lana J., Noyce, Alastair J., Daneshmand, Ali, Blauwendraat, Cornelis, Marek, Ken, Scholz, Sonja W., Singleton, Andrew B., Nalls, Mike A., Campbell, Roy H., Faghri, Faraz · 2022 · npj Parkinson's Disease
Cited by 115

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

The clinical manifestations of Parkinson’s disease (PD) are characterized by heterogeneity in age at onset, disease duration, rate of progression, and the constellation of motor versus non-motor features. There is an unmet need for the characterization of distinct disease subtypes as well as improved, individualized predictions of the disease course. We used unsupervised and supervised machine learning methods on comprehensive, longitudinal clinical data from the Parkinson’s Disease Progression Marker Initiative ( n = 294 cases) to identify patient subtypes and to predict disease progression. The resulting models were validated in an independent, clinically well-characterized cohort from the Parkinson’s Disease Biomarker Program ( n = 263 cases). Our analysis distinguished three distinct disease subtypes with highly predictable progression rates, corresponding to slow, moderate, and fast disease progression. We achieved highly accurate projections of disease progression 5 years after initial diagnosis with an average area under the curve (AUC) of 0.92 (95% CI: 0.95 ± 0.01) for the slower progressing group (PDvec1), 0.87 ± 0.03 for moderate progressors, and 0.95 ± 0.02 for the fast-progressing group (PDvec3). We identified serum neurofilament light as a significant indicator of fast disease progression among other key biomarkers of interest. We replicated these findings in an independent cohort, released the analytical code, and developed models in an open science manner. Our data-driven study provides insights to deconstruct PD heterogeneity. This approach could have immediate implications for clinical trials by improving the detection of significant clinical outcomes. We anticipate that machine learning models will improve patient counseling, clinical trial design, and ultimately individualized patient care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41531-022-00439-z

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 115

Metadata

Authors
Dadu, A., Satone, V., Kaur, R., Hashemi, S. H., Leonard, H., Iwaki, H., Makarious, M. B., Billingsley, K. J., Bandres‐Ciga, S., Sargent, L. J., Noyce, A. J., Daneshmand, A., Blauwendraat, C., Marek, K., Scholz, S. W., Singleton, A. B., Nalls, M. A., Campbell, R. H., & Faghri, F.
Venue
npj Parkinson's Disease
Published
2022-12-16
Volume
8
Issue
1
Pages
172-172
ISSN
2373-8057 (ISSN-L)
OpenAlex
W4312067188
Cited by
115
References
17
FWCI
10.12
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts. https://app.cochat.ai/papers/10.1038/s41531-022-00439-z
The paper
Dadu, A., Satone, V., Kaur, R., Hashemi, S. H., Leonard, H., Iwaki, H., Makarious, M. B., Billingsley, K. J., Bandres‐Ciga, S., Sargent, L. J., Noyce, A. J., Daneshmand, A., Blauwendraat, C., Marek, K., Scholz, S. W., Singleton, A. B., Nalls, M. A., Campbell, R. H., & Faghri, F. (2022). Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts. npj Parkinson's Disease. https://doi.org/10.1038/s41531-022-00439-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.